VIB Vermoegen AG
XBER:VIH1

Watchlist Manager
VIB Vermoegen AG Logo
VIB Vermoegen AG
XBER:VIH1
Watchlist
Price: 9.96 EUR -1.19% Market Closed
Market Cap: 1.2B EUR
Have any thoughts about
VIB Vermoegen AG?
Write Note
Section:
 

Relative Value

The Relative Value of one VIH1 stock under the Base Case scenario is 33.87 EUR. Compared to the current market price of 9.96 EUR, VIB Vermoegen AG is Undervalued by 71%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIH1 Relative Value
Base Case
33.87 EUR
Undervaluation 71%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
77
vs Industry
52
Median 3Y
4.9
Median 5Y
7.2
Industry
3.6
Forward
3
More Details
3.7
P/E
P/E
Price to Earnings
3.7
vs History
71
vs Industry
55
Median 3Y
4.2
Median 5Y
10.1
Industry
16.7
Forward
8.5
More Details
4.8
P/OCF
P/OCF
Price to OCF
4.8
vs History
90
vs Industry
56
Median 3Y
7.5
Median 5Y
9.9
Industry
10.9
More Details
229.8
P/FCFE
P/FCFE
Price to FCFE
229.8
vs History
30
vs Industry
2
Median 3Y
235.4
Median 5Y
20.4
Industry
13.3
More Details
0.4
P/B
P/B
Price to Book Value
0.4
vs History
90
vs Industry
74
Median 3Y
0.7
Median 5Y
1.2
Industry
0.8
More Details
12.1
EV/S
EV/S
Enterprise Value to Sales
12.1
vs History
55
vs Industry
34
Median 3Y
11.4
Median 5Y
13.2
Industry
6.6
Forward
10.6
More Details
15.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
15.2
vs History
55
vs Industry
47
Median 3Y
13.9
Median 5Y
15.8
Industry
11.9
More Details
14.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.5
vs History
63
vs Industry
58
Median 3Y
13.8
Median 5Y
17.8
Industry
15.8
Forward
13.9
More Details
24.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.1
vs History
12
vs Industry
51
Median 3Y
18.3
Median 5Y
19.5
Industry
19
Forward
21.9
More Details
16.8
EV/OCF
EV/OCF
Enterprise Value to OCF
16.8
vs History
61
vs Industry
46
Median 3Y
16.6
Median 5Y
18.7
Industry
18.5
More Details
16.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
16.9
vs History
52
vs Industry
40
Median 3Y
16.8
Median 5Y
17.4
Industry
20.1
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
85
vs Industry
59
Median 3Y
0.7
Median 5Y
1
Industry
0.7
More Details

Multiples Across Competitors

VIH1 Competitors Multiples
VIB Vermoegen AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
VIB Vermoegen AG
XBER:VIH1
325.3m EUR 3.5 3.7 14.5 24.1
DE
Vonovia SE
XETRA:VNA
24.2B EUR 50.2 -8.5 -35.4 -31.7
PH
SM Prime Holdings Inc
XPHS:SMPH
715.6B PHP 5.4 16.8 12.7 15.6
HK
Swire Properties Ltd
HKEX:1972
91.1B HKD 6.2 41.2 14.8 14.8
CN
Zhejiang China Commodities City Group Co Ltd
SSE:600415
79.9B CNY 5.7 29.7 26.4 26.4
IL
Azrieli Group Ltd
TASE:AZRG
34.9B ILS 11.3 16.8 17.6 18
DE
Deutsche Wohnen SE
XETRA:DWNI
9.2B EUR 7.6 -37.3 16.2 23.4
SG
Capitaland Investment Ltd
SGX:9CI
13B SGD 4.7 71.9 22.6 26.5
BM
Hongkong Land Holdings Ltd
SGX:H78
9.5B USD 4.4 -8.8 22.5 23.1
SE
Sagax AB
STO:SAGA A
105.5B SEK 21.9 27.6 34.4 34.4
CN
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
64.5B HKD 3.8 17.6 11.9 11.9
P/E Multiple
Earnings Growth P/E to Growth
DE
VIB Vermoegen AG
XBER:VIH1
Average P/E: 28.2
3.7
-61%
N/A
DE
Vonovia SE
XETRA:VNA
Negative Multiple: -8.5 N/A N/A
PH
S
SM Prime Holdings Inc
XPHS:SMPH
16.8
35%
0.5
HK
S
Swire Properties Ltd
HKEX:1972
41.2
225%
0.2
CN
Zhejiang China Commodities City Group Co Ltd
SSE:600415
29.7
59%
0.5
IL
Azrieli Group Ltd
TASE:AZRG
16.8
-36%
N/A
DE
Deutsche Wohnen SE
XETRA:DWNI
Negative Multiple: -37.3 N/A N/A
SG
Capitaland Investment Ltd
SGX:9CI
71.9
393%
0.2
BM
Hongkong Land Holdings Ltd
SGX:H78
Negative Multiple: -8.8 N/A N/A
SE
S
Sagax AB
STO:SAGA A
27.6
N/A N/A
CN
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
17.6
70%
0.3

See Also

Summary
VIH1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIH1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIH1 stock valuation using valuation multiples.
Wall Street Estimates
VIH1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIH1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.